Project Details
Description
A Phase I Trial of Pevonedistat Given in Combination with Fludarabine, Cytarabine, and Azacitidine in Children, Adolscents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia
| Status | Finished |
|---|---|
| Effective start/end date | 10/22/19 → 10/21/22 |
Funding
- THE CHILDREN'S HOSPITAL OF PHILADELPHIA
- MILLENNIUM PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.